Firefly Neuroscience, Inc. (AIFF) NASDAQ
2.61
+0.93(+55.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.61
+0.93(+55.36%)
Currency In USD
| Previous Close | 1.68 |
| Open | 2.06 |
| Day High | 2.68 |
| Day Low | 2.01 |
| 52-Week High | 5.1 |
| 52-Week Low | 0.62 |
| Volume | 73.03M |
| Average Volume | 8.2M |
| Market Cap | 37.1M |
| PE | -1.15 |
| EPS | -2.26 |
| Moving Average 50 Days | 1.14 |
| Moving Average 200 Days | 2.08 |
| Change | 0.93 |
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
Newsfile
Mar 06, 2025 12:30 PM GMT
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: